Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

New Drug Helps Asbestos-Linked Cancer

First Treatment for Rare Lung Cancer
WebMD Health News

Feb. 5, 2004 -- It's not a cure. But a new drug offers precious extra months of life to people with a rare, asbestos-linked cancer.

The drug, Alimta, from Eli Lilly and Company, today received FDA approval for use in combination with cisplatin chemotherapy. It will be used to treat malignant mesothelioma. It strikes some 2,000 Americans each year, mostly due to asbestos exposure. Worldwide, as many as 15,000 people each year are told they will die of mesothelioma.

It's a terrible disease. Tumors grow on the outer lining of the lung. They squeeze the lung, causing pain and making it hard to breathe. Symptoms don't appear until the cancer is very advanced. Most patients survive only nine to 13 months after diagnosis.

"Until now, when a patient was diagnosed with this disease, the oncologist said, 'Go home.' There was no treatment. There have been 50 failed attempts with other drugs to find some hope," Paolo Paoletti, MD, Lilly vice president for oncology, clinical research, and oncology products, tells WebMD.

In a clinical trial, most patients who added Alimta to their chemotherapy regimens survived at least 12 months. Half of these patients were still alive a year after treatment, while only a third of patients treated with chemotherapy alone survived this long.

Alimta is a toxic drug. But Paoletti says that by giving patients large doses of B vitamins, most of the toxicity is avoided.

"Usually chemotherapy is associated with a high level of toxicity," Paoletti says. "This drug does not have that. By adding low-dose folic acid and vitamin B-12 we significantly reduce the toxicity."

Lilly tells WebMD the drug should be available to pharmacies within a month. Meanwhile, Lilly will make the drug available to all mesothelioma patients.

Currently, the FDA approves Alimta only for mesothelioma. But studies are under way to see if the drug can help a large number of other tumors, including cancers of the lung, pancreas, breast, colon, stomach, and bladder.

Lilly is a WebMD sponsor.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas